Experiment 67837
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | BLACKHALL,FH: RANSON,M: RADFORD,JA: HACOCK,BW: SOUKOP,M: MC GOWN,AT: ROBBINS,A: HALBERT,G: JAYSON,GC:. (2001). A PHASE II TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA.. 84(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY, 17 PATIENTS WITH PROGRESSIVE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH CHEMOTHERAPHY, RECEIVED A MEDIAN OF 6 (RANGE 1-9) INTRAVENOUS INFUSIONS OF 25 UG/M2 BRYOSTATIN 1 GIVEN ONCE WEEKLY OVER 24 HOURS. IN 14 EVALUABLE PATIENTS NO RESPONSES WERE SEEN. STABLE DISEASE WAS ATTAINED IN ONE PATIENT FOR 9 MONTHS. THE PRINCIPAL TOXICITIES WERE MYALGIA AND PHLEBITIS. |
| Dose amount | 25.0 MCG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |